Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, November 2003, p. 1123-1128, Vol. 10, No. 6
1071-412X/03/$08.00+0 DOI: 10.1128/CDLI.10.6.1123-1128.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Divisions of Immunologic and Infectious Diseases, Joseph Stokes, Jr., Research Institute, The Children's Hospital of Philadelphia, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
Received 21 February 2003/ Returned for modification 22 April 2003/ Accepted 23 July 2003
CCR5, a ß-chemokine receptor, plays an important role in human immunodeficiency virus (HIV) infection of human immune cells, as it is a primary coreceptor for HIV entry into macrophages. We have applied a newly developed real-time reverse transcriptase PCR (RT-PCR) assay for the quantification of CCR5 mRNA in human blood immune cells. The CCR5 real-time RT-PCR assay has a sensitivity of 100 mRNA copies, with a dynamic range of detection between 102 and 106 copies of the CCR5 mRNA transcripts per reaction. The assay is highly reproducible, with an intra-assay coefficient of variation of the threshold cycle of less than 2.07%. When used for quantification of CCR5 mRNA in human monocyte-derived macrophages (MDM) and peripheral blood lymphocytes (PBL), the assay has precision and reproducibility. MDM expressed higher levels of CCR5 mRNA than did PBL. Thus, this assay has the potential and a wide application for the investigation of the role of CCR5 in inflammatory diseases and viral infections, including HIV disease.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»